Clinical Trial Management Statistics 2023
– Everything You Need to Know

At LLCBuddy, we don't just offer information; we provide a curated experience backed by extensive research and expertise. Led by Steve Goldstein, a seasoned expert in the LLC formation sector, our platform is built on years of hands-on experience and a deep understanding of the nuances involved in establishing and running an LLC. We've navigated the intricacies of the industry, sifted through the complexities, and packaged our knowledge into a comprehensive, user-friendly guide. Our commitment is to empower you with reliable, up-to-date, and actionable insights, ensuring you make informed decisions. With LLCBuddy, you're not just getting a tutorial; you're gaining a trustworthy partner for your entrepreneurial journey.

Clinical Trial Management Statistics 2023: Facts about Clinical Trial Management outlines the context of what’s happening in the tech world.

LLCBuddy editorial team did hours of research, collected all important statistics on Clinical Trial Management, and shared those on this page. Our editorial team proofread these to make the data as accurate as possible. We believe you don’t need to check any other resources on the web for the same. You should get everything here only 🙂

Are you planning to form an LLC? Maybe for educational purposes, business research, or personal curiosity, whatever the reason is – it’s always a good idea to gather more information about tech topics like this.

How much of an impact will Clinical Trial Management Statistics have on your day-to-day? or the day-to-day of your LLC Business? How much does it matter directly or indirectly? You should get answers to all your questions here.

Please read the page carefully and don’t miss any words.

Top Clinical Trial Management Statistics 2023

☰ Use “CTRL+F” to quickly find statistics. There are total 10 Clinical Trial Management Statistics on this page 🙂

Clinical Trial Management “Latest” Statistics

  • Approximately 40% of clinical trials are supported by noncommercial sponsors, mostly academics, and the pharmaceutical sector funds 60%.[1]
  • 97% of those that responded and used new techniques for clinical trials during the pandemic said their organization would continue to use at least one of these new techniques.[2]
  • 58% of respondents, a small majority, said that their organizations intend to provide patients with the choice of how they participate in clinical studies.[2]
  • The COVID-19 pandemic, according to 76% of respondents in an industry poll conducted by Informa Pharma Intelligence and Oracle last year, has increased the use of decentralized clinical trial approaches.[2]
  • Most survey participants anticipate a rise in fit-for-purpose, hybrid, and/or decentralized clinical trial models in the future, 63% of whom expect these models to be utilized for both new studies and the restarts of current trials.[2]
  • Survey participants who used novel clinical trial techniques during the pandemic anticipated their organizations would utilize hybrid models more often (44%) and fit-for-purpose models more frequently (42%).[2]

Clinical Trial Management “Other” Statistics

  • The compliance rate increased between April 2019 and June 2022 from 24% to 64% for noncommercial sponsors to 77% to 86% for commercial sponsors.[1]
  • Among the four models: evaluated, site-based, fit-for-purpose, hybrid, and decentralized models, respondents expect a 24% drop in site usage.[2]
  • A whopping 87% of survey participants reported being able to utilize most or all of the extra data their recently deployed procedures have produced.[2]
  • 76% of responses were from biopharmaceutical businesses, while the remaining respondents were from medical device companies and CROs.[2]

Also Read

Reference


  1. europa – https://www.ema.europa.eu/en/human-regulatory/research-development/clinical-trials-human-medicines
  2. oracle – https://www.oracle.com/industries/life-sciences/clinical-research/clinical-trials-post-covid-research/

About Author & Editorial Staff

Steve Goldstein, founder of LLCBuddy, is a specialist in corporate formations, dedicated to guiding entrepreneurs and small business owners through the LLC process. LLCBuddy provides a wealth of streamlined resources such as guides, articles, and FAQs, making LLC establishment seamless. The diligent editorial staff makes sure content is accurate, up-to-date information on topics like state-specific requirements, registered agents, and compliance. Steve's enthusiasm for entrepreneurship makes LLCBuddy an essential and trustworthy resource for launching and running an LLC.

Leave a Comment